These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38808829)

  • 1. Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center.
    Castelli GM; Friederich F; Wiemann AF; Santos GD; Pitrez PM
    J Bras Pneumol; 2024 May; 50(2):e20230405. PubMed ID: 38808829
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical remission with biologic therapies in severe asthma: a matter of definition.
    ; McDowell PJ; McDowell R; Busby J; Eastwood MC; Patel PH; Jackson DJ; Mansur A; Patel M; Burhan H; Doe S; Chaudhuri R; Gore R; Dodd JW; Subramanian D; Brown T; Heaney LG
    Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38901893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhaled corticosteroid use on weight (BMI) in pediatric patients with moderate-severe asthma.
    Han J; Nguyen J; Kim Y; Geng B; Romanowski G; Alejandro L; Proudfoot J; Xu R; Leibel S
    J Asthma; 2019 Mar; 56(3):263-269. PubMed ID: 29672188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of asthma severity on long-term asthma control.
    Sheikh SI; Ryan-Wenger NA; Pitts J; Nemastil CJ; Palacios S
    J Asthma; 2021 Jun; 58(6):725-734. PubMed ID: 32138568
    [No Abstract]   [Full Text] [Related]  

  • 5. Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control.
    Molimard M; Mala L; Bourdeix I; Le Gros V
    Respir Med; 2014 Apr; 108(4):571-6. PubMed ID: 24565601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
    Wu WW; Wang G
    Chest; 2024 May; 165(5):e157-e158. PubMed ID: 38724156
    [No Abstract]   [Full Text] [Related]  

  • 7. Current practices and newer agents for the management of pediatric asthma.
    DeBisschop ME
    JAAPA; 2000 Jun; 13(6):20-2, 25-6, 29-30 passim. PubMed ID: 11503239
    [No Abstract]   [Full Text] [Related]  

  • 8. Uncontrolled asthma and its risk factors in Chinese children: A cross-sectional observational study.
    Xiang L; Zhao J; Zheng Y; Liu H; Hong J; Bao Y; Chen A; Deng L; Ji W; Zhong N; Shen K
    J Asthma; 2016 Sep; 53(7):699-706. PubMed ID: 27043467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic burden of severe asthma among US patients treated with biologic therapies.
    Reibman J; Tan L; Ambrose C; Chung Y; Desai P; Llanos JP; Moynihan M; Tkacz J
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):318-325.e2. PubMed ID: 33775904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory management of pediatric asthma.
    Gan VN; Gruchalla R
    Respir Care Clin N Am; 2000 Mar; 6(1):87-133. PubMed ID: 10639559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Younger asthmatics are less likely to receive inhaled corticosteroids and asthma education after admission for exacerbation.
    Lintzenich A; Teufel RJ; Basco WT
    Clin Pediatr (Phila); 2010 Dec; 49(12):1111-6. PubMed ID: 20724325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer Biological Agents in the Treatment of Severe Asthma: Real-World Results from a Tertiary Referral Center.
    Voelker D; Almodallal Y; Scrodin MD; Lim K; Keogh K; Patel A; Iyer V
    Lung; 2020 Aug; 198(4):653-659. PubMed ID: 32583059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription habits for preventative medications among pediatric emergency department physicians at an inner-city teaching hospital.
    Lovinsky S; Rastogi D
    J Asthma; 2010 Nov; 47(9):1011-4. PubMed ID: 20868318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Severe Asthma in the Era of Biologic Treatments.
    Teague WG
    Pediatr Allergy Immunol Pulmonol; 2020 Sep; 33(3):118-120. PubMed ID: 32953228
    [No Abstract]   [Full Text] [Related]  

  • 15. [Asthma mortality and utilization of antiasthmatic agents in Finland].
    Savolainen T; Liippo K; Klaukka T; Huhti E; Helenius H; Tala E
    Duodecim; 1996; 112(14):1287-92. PubMed ID: 10596099
    [No Abstract]   [Full Text] [Related]  

  • 16. Remission in the World of Severe Asthma.
    Pavord ID
    Am J Respir Crit Care Med; 2024 Oct; 210(7):855-857. PubMed ID: 38861332
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry.
    McDowell PJ; McDowell R; Busby J; Eastwood MC; Patel PH; Jackson DJ; Mansur A; Patel M; Burhan H; Doe S; Chaudhuri R; Gore R; Dodd JW; Subramanian D; Brown T; Heaney LG;
    Eur Respir J; 2023 Dec; 62(6):. PubMed ID: 37857423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of inpatient care for asthma: challenges and opportunities.
    Kattan M
    Pediatrics; 2008 Dec; 122(6):1369-70. PubMed ID: 19047258
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing patterns of asthma controller therapy for children in UK primary care: a cross-sectional observational study.
    Thomas M; Murray-Thomas T; Fan T; Williams T; Taylor S
    BMC Pulm Med; 2010 May; 10():29. PubMed ID: 20470409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to clinical remission in severe asthma.
    Farinha I; Heaney LG
    Respir Res; 2024 Apr; 25(1):178. PubMed ID: 38658975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.